Renal Cell Carcinoma

Systemic therapy for mRCC: second line and beyond

Earn accreditation points

Finish 5 case(s) answer 10 question(s) and Earn 1 credit.

Continue
Освітня мета: Recognise the optimal treatment strategy for patients with advanced renal cell carcinoma (RCC) progressing after previous therapy.
Спеціальність: Medical oncology
Цільова аудиторія: Specialists (CME: basic, intermediate), Residents (senior)
Останнє оновлення: January 2024
Фон:

Regulatory approval status of drugs for the treatment of advanced/metastatic RCC, mentioned in the CME courses on first- and later-line management (status 10 January 2024)

This educational platform includes case challenges with treatment options that may not be indicated for this use in your country. Please refer to your local prescribing information.